Cannabis Moves to Schedule III: What the April 2026 Rescheduling Means for US Producers
On April 28, 2026 the US moved FDA-approved and state-licensed medical marijuana to Schedule III. Here is what the rescheduling means for producers: 280E tax relief, a new DEA registration pathway, the unresolved banking gap, and the pending hearing and litigation.









